Objective  To determine the net financial gain or loss for herpes zoster vaccination services provided to patients from the perspective of an independent community pharmacy.

Design  Retrospective review of pharmacy records over the program's initial 11-month period.

Setting  Independent community pharmacy in Iowa City, IA.

Participants  Patients received immunization with the herpes zoster vaccine from a certified pharmacist.

Intervention  Herpes zoster vaccination services were provided to the patient and documented by the pharmacist.

Main outcome measure  Net financial gains or losses were calculated for the herpes zoster vaccination program. Sensitivity analyses were based on costs that might be incurred during program start-up.

Results  478 patients received zoster vaccination services over the initial 11-month period. A net financial gain for the herpes zoster vaccination program was achieved, with a net profit of $15.02, or 8.15%, per vaccination.

Conclusion  Revenues for this vaccination program exceeded its costs from the independent community pharmacy perspective.